







This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To

Researchers say a lifestyle-only treatment which includes increased physical activity may be the best prescription for preventing vascular and other issues that can lead to dementia. Their prescription: sit less and move more for mildly high blood pressure and cholesterol, which helps address vascular issues.

VIDEO: Dr. Rudy Tanzi of Massachusetts General Hospital and the Cure Alzheimer’s Fund explains the latest progress on Alzheimer’s treatment — and prevention. Watch now.

Lecanemab (marketed as Leqembi) is today’s top Alzheimer’s drug. Why does equitable access to this drug remain a significant challenge? What needs to be done?

Researchers found FDA-approved Rolipram promotes the removal of abnormal tau proteins, improving memory. This could be big news for tau-based brain diseases such as Alzheimer’s,
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On